Anatol J Cardiol. 2021; 25(1): 7-16 | DOI: 10.14744/AnatolJCardiol.2020.99469
Department of Emergency, the First Affiliated Hospital, Guangxi Medical University; Guangxi-China
Keywords: tirofiban, no-reflow, percutaneous coronary intervention, combination therapy
A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention
Qian Zeng, Long-Dan Zhang, Wei WangDepartment of Emergency, the First Affiliated Hospital, Guangxi Medical University; Guangxi-China
Keywords: tirofiban, no-reflow, percutaneous coronary intervention, combination therapy
Qian Zeng, Long-Dan Zhang, Wei Wang. A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention. Anatol J Cardiol. 2021; 25(1): 7-16
Corresponding Author: Wei Wang, China
Corresponding Author: Wei Wang, China
